Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Apnimed
AddedFeb 13, 2024
UpdatedJun 18, 2026
Apnimed

Apnimed

Series C

Apnimed Inc: A clinical-stage company innovating pharmacologic therapies for sleep disorders in Massachusetts.

HQ
Cambridge, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded in Massachusetts, Apnimed Inc is a clinical-stage company dedicated to the discovery and development of novel pharmacologic therapies for sleep apnea and related disorders. The company's core mission is to transform the treatment of sleep disorders through innovative drug therapies, aiming to improve patient outcomes and quality of life. Apnimed's primary focus is on obstructive sleep apnea (OSA), and its leading product candidate, AD109, is currently in Phase 3 clinical trials.

Apnimed has garnered recognition for its groundbreaking research and has been named one of the best places to work by the Boston Business Journal. The company boasts a strong team of experts and advisors in the fields of sleep medicine and pharmacology. Apnimed's achievements include advancing its lead candidate through significant clinical milestones, positioning it as a potential game-changer in the treatment of OSA. The company's impact lies in its innovative approach to addressing unmet medical needs in sleep disorders.

Apnimed - Similar Companies

Apnicure logo

Apnicure

apnicure.com

Apnex Medical logo

Apnex Medical

Somnea Health logo

Somnea Health

somnea.co

RespireRx Pharmaceuticals logo

RespireRx Pharmaceuticals

respirerx.com

ResMed logo

ResMed

resmed.com

Lunosa logo

Lunosa

XII Medical logo

XII Medical

xiimedical.com

StimAire logo

StimAire

stimaire.com

Invicta Medical logo

Invicta Medical

Airing logo

Airing

fundairing.com

Sommetrics logo

Sommetrics

sommetrics.com

Appian Medical logo

Appian Medical

appianmed.com

Cryosa logo

Cryosa

cryosa.com

Somnus Therapeutics logo

Somnus Therapeutics

somnusthera.com

Anapneo Therapeutics logo

Anapneo Therapeutics

Apnimed - Quick Facts

Who are Apnimed's competitors?

Companies similar to Apnimed include Apnicure, Apnex Medical, Somnea Health and RespireRx Pharmaceuticals.

When was Apnimed founded?

Apnimed was founded in 2017.

Where is Apnimed's headquarters located?

Apnimed's headquarters is located in Cambridge, MA, US.

When was Apnimed's last funding round?

Apnimed's most recent funding round was for $79.7M (USD) in December 2022.

How much has Apnimed raised to-date?

As of Dec 23, 2022, Apnimed has raised a total of $207.8M (USD).

How many employees does Apnimed have?

Apnimed has 29 employees as of Feb 5, 2024.

Apnimed - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research